Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.

ABSTRACT: We report the discovery and characterization of a series of benzoisothiazolone inhibitors of PHOSPHO1, a newly identified soluble phosphatase implicated in skeletal mineralization and soft tissue ossification abnormalities. High-throughput screening (HTS) of a small molecule library led to the identification of benzoisothiazolones as potent and selective inhibitors of PHOSPHO1. Critical structural requirements for activity were determined, and the compounds were subsequently derivatized and measured for in vitro activity and ADME parameters including metabolic stability and permeability. On the basis of its overall profile the benzoisothiazolone analogue 2q was selected as MLPCN probe ML086.

SUBMITTER: Bravo Y 

PROVIDER: S-EPMC4170737 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature